unidad farmacología por aparatos sistemas. farmacología del aparato circulatorio . fármacos ionotropos. gasto cardíaco: volumen de sangre impulsado por el. Edición: Comisión de Farmacia y Terapéutica. Redacción: Servicio de Farmacología Clínica. Solicitud de Inclusión de nuevos Fármacos en la. Tamargo J. Farmacología clínica de los calcioantagonistas. Potenciales diferencias basadas en la duración de acción y tipo de formulación. Hipertensión

Author: Nisho Zulkihn
Country: Fiji
Language: English (Spanish)
Genre: Politics
Published (Last): 8 October 2004
Pages: 485
PDF File Size: 6.31 Mb
ePub File Size: 3.89 Mb
ISBN: 571-3-71905-512-6
Downloads: 14617
Price: Free* [*Free Regsitration Required]
Uploader: Fenrira

Spironolactone and its main metabolite canrenoic acid, block hKv1. Relaxant effects of the soluble guanylate cyclase activator and NO sensitizer YC-1 in piglet pulmonary arteries.

Cardiovasc Haematol disorders-Drug Target ;9: Expert Opin Investig Drugs ; Rev Esp Cardiol ; J Pharmacol Exp Ther. Chronic atrial fibrillation increases microRNA- 21 in human atrial myocites decreasing L-type calcium current. Rev Esp Cardiol ;6 Supl D: Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation.

Epub Jun 9. Investigational calcium channel blockers for the treatment of hypertension.


Mol Biol Cell ; Expert Opin Drug Saf ;5: Investigational positive inotropic agents for acute heart failure. Soluble guanylyl cyclase during postnatal porcine pulmonary maturation. The Renin-Angiotensin System and Bone.

Publicaciones en revistas del jcr

Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Rev Esp Cardiol ;7 Supl. New Drugs for Acute Heart Failure.

New insights in the pharmacological therapy of arterial hypertension. Tamargo M, Tamargo J. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: An update on atrial fibrillation in Nature Drug Discovery Reviews ; Old and new molecular mechanisms associated with platelet resistance to antithrombotics.

Calcio-antagonistas by Leslie Melissa Jiménez Buendía on Prezi

PlosOne 8 Ruilope LM, Tamargo J. Epub Apr 3.

Mohler PJ, Abriel H. Proteomics Clin Appl ;2: From pathophysiology to treatment.

Antihypertensive efficacy calciozntagonistas tolerability oflercanidipine in daily clinical practice. Epub Apr Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. Br J Pharmacol ; Trends Pharmacol Sci ; Proteomic study of plasma from moderate hypercholesterolemic patients. Curr Opin Investig Drugs ; Diuretics in the treatment of hypertension. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients.


Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations.

Expert Opin Drug Discov. Rev Esp Cardiol ;6 Supl B: A dangerous drug in atrial fibrillation?. Guidelines on the management of stable angina pectoris: Rev Esp Cardiol ;10 supl B: Twenty-five years in the making: Diab Vasc Dis Res. Structural bases of drugs that increase cardiac ffarmacologia rectifier Kir2.

Nitric oxide inhibits Kv4. Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation. Platelet content of nitric oxide synthase 3 phosphorylated at serie is associated with the functional response of platelet calcioaantagonistas aspirin. Circulation Circ Arrhythm Electrophysiol.

Reversal strategies for non-vitamin K antagonist oral anticoagulants: Circulation arrhythmia and electrophysiology.